Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOC1 antibody (AA 35-48)

This Rabbit Polyclonal antibody specifically detects APOC1 in IHC and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7144415

Quick Overview for APOC1 antibody (AA 35-48) (ABIN7144415)

Target

See all APOC1 Antibodies
APOC1 (Apolipoprotein C-I (APOC1))

Reactivity

  • 57
  • 11
  • 5
  • 4
  • 4
  • 1
  • 1
Human

Host

  • 52
  • 18
  • 9
  • 3
Rabbit

Clonality

  • 60
  • 22
Polyclonal

Conjugate

  • 56
  • 7
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This APOC1 antibody is un-conjugated

Application

  • 59
  • 50
  • 39
  • 34
  • 16
  • 10
  • 6
  • 5
  • 2
  • 2
  • 2
  • 1
Immunohistochemistry (IHC), ELISA
  • Binding Specificity

    • 8
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 35-48

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human Apolipoprotein C-I protein (35-48aa)

    Isotype

    IgG
  • Application Notes

    Recommended dilution: IHC:1:100-1:500,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    APOC1 (Apolipoprotein C-I (APOC1))

    Alternative Name

    APOC1

    Background

    Background: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

    Aliases: Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I], APOC1

    UniProt

    P02654

    Pathways

    Apoptosis
You are here:
Chat with us!